Hinge Health (NASDAQ: HNGE) director to sell 1,200 shares under Rule 144

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) had a notice filed for a planned sale of common stock under Rule 144 by director Kristina Murphy Leslie. The notice covers 1,200 shares of common stock, held as restricted stock acquired on 04/01/2025, to be sold through Morgan Stanley Smith Barney LLC, with an indicated aggregate value of $105,876.00 and a proposed sale date of 08/20/2026 on the NYSE.

Key Figures

Shares to be sold: 1,200 shares of common stock Aggregate value: $105,876.00 Proposed sale date: 08/20/2026 +1 more

4 metrics

Shares to be sold 1,200 shares of common stock Proposed Rule 144 sale by director Kristina Murphy Leslie

Aggregate value $105,876.00 Indicated value of 1,200 Hinge Health, Inc. shares in the planned sale

Proposed sale date 08/20/2026 Planned date for sale of Hinge Health, Inc. common stock on NYSE

Acquisition date of restricted stock 04/01/2025 Date the 1,200 restricted shares were acquired from the issuer

Key Terms

Rule 144, Restricted Stock, common stock

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 04/01/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

common stock financial

"Name of Issuer | HINGE HEALTH, INC. ... Common | Morgan Stanley Smith Barney LLC"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider sale was reported for HNGE in this Form 144 notice?

The notice reports a planned sale of 1,200 shares of Hinge Health, Inc. common stock by director Kristina Murphy Leslie under Rule 144, with an indicated aggregate value of $105,876.00 to be sold through Morgan Stanley Smith Barney LLC on the NYSE.

Who is the selling security holder for HNGE in this Rule 144 notice?

The selling security holder is Kristina Murphy Leslie, identified as a Director of Hinge Health, Inc. The notice states that the securities are being sold for her account under the provisions of Rule 144.

How many HNGE shares are covered and what is their value?

The notice covers 1,200 shares of Hinge Health, Inc. common stock, with an indicated aggregate value of $105,876.00. These shares are described as restricted stock and are planned to be sold on the NYSE.

When were the HNGE shares acquired and what type are they?

The shares were acquired on 04/01/2025 and are described as Restricted Stock from the issuer, Hinge Health, Inc. They are common stock shares proposed to be sold under Rule 144.

When is the proposed sale date for the HNGE shares in this notice?

The proposed sale date for the 1,200 shares of Hinge Health, Inc. common stock is 08/20/2026, according to the securities information section, with the sale expected to occur on the NYSE.

Which broker is handling the planned HNGE Rule 144 sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, listed with an address at 1 New York Plaza, New York, NY 10004, as the broker for the proposed Rule 144 transaction in Hinge Health, Inc. shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 06:23 PM Accepted by SEC EDGAR 08/20/2026 - 06:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001307207
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HINGE HEALTH, INC.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	(415) 726-2206
Name of Person for Whose Account the Securities are To Be Sold	KRISTINA LESLIE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1200	105876.00	62468721	08/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2025	Restricted Stock	Issuer			1200	04/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kristina Murphy Leslie
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)